Scott Gordon | IR |
Christopher Missling | President & CEO |
Sandra Boenisch | Principal Financial Officer |
Jotin Marango | Roth Capital |
Ram Selvaraju | H.C. Wainwright |
Good afternoon my name is Michelle, and I will be your conference call operator for today's call. Welcome to the Anavex Life Sciences Fiscal 2019 First Quarter Financial Results Conference Call. At this time all participants are in a listen only mode.
As a reminder this conference call is being recorded. I will now like to introduce your host for today's conference, Mr.